Categories AlphaGraphs, Analysis, Other Industries
Plug Power Q2 earnings preview: Management sees stellar results
Plug Power (NASDAQ: PLUG) is slated to report second-quarter 2019 earnings results on Tuesday, August 6, before the regular trading hours. The fuel-cell specialist has seen its stock slide 26.3% in the past four months, underperforming the industry, and will be hoping to turn things around with Q2 results.
The company had last month stated in a press release that it is expecting record Q2 results, as it is on track to deploy approximately 2,000 fuel cell units, a 70% jump from the year-ago period. Plug Power added that it remains on target to meet full-year guidance of $235 million to $245 million in gross billings and positive adjusted EBITDA for the full year of 2019, a first.
While this gives a somewhat positive picture of the stock, let’s not forget it’s not devoid of headwinds. In three of the last four quarters, the company failed to beat bottom-line estimates. During the first quarter, Plug Power posted wider losses on a 30% decline in revenues, even as the market was expecting narrower losses.
For the second quarter, analysts expect a 35% jump in revenues to $53.74 million, helped by its increased adoption in the electric vehicle industry.
Meanwhile, the Latham, New York-based firm is expected to report a net loss of 1 cent per share, compared to a loss of 12 cents per share it reported in the same quarter last year. The bottom-line for the quarter could be impacted by the constant increase in operating and infrastructure expenses as well as foreign currency weakness.
During the conference call, look out for any management commentary on the company’ strategy to peg its rising liabilities.
PLUG stock has gained 57% so far this year and 3.5% in the trailing 52 weeks. The stock has a 12-month average price target of $3.42, which is at a 66% upside from its Monday trading price.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Comments
Comments are closed.